Epitope-dependent blocking of the angiotensin-converting enzyme dimerization by monoclonal antibodies to the N-terminal domain of ACE: possible link of ACE dimerization and shedding from the cell surface

Biochemistry. 2003 Jun 17;42(23):6965-76. doi: 10.1021/bi034645y.

Abstract

In a biomembrane modeling system, reverse micelles, somatic ACE forms dimers via carbohydrate-mediated interaction, providing evidence for the existence of a carbohydrate-recognizing domain on the ACE molecule. We localized this putative region on the N-domain of ACE using monoclonal antibodies (mAbs) to seven different epitopes of ACE. Two mAbs, 9B9 and 3G8, directed to distinct, but overlapping, epitopes of the N-domain of ACE shielded the CRD. Only "simple" ACE-antibody complexes were found in the system. Five mAbs allowed the formation of "double" antibody-ACE-ACE-antibody complexes via carbohydrate-mediated interactions. The results were confirmed using the ACE N- and C-domains. Testicular ACE was unable to form carbohydrate-mediated ACE dimers in the reverse micelles, while the N-domain of ACE, obtained by limited proteolysis of the parent full-length ACE, retained the ability to form dimers. Furthermore, mAb 3G8, which blocked ACE dimerization in micelles, significantly inhibited ACE shedding from the surface of ACE-expressing cells. Galactose prevented ACE dimerization in reverse micelles and also affected antibody-induced ACE shedding in an epitope-dependent manner. Restricted glycosylation of somatic ACE, obtained by the treatment of CHO-ACE cells with the glucosidase inhibitor N-butyldeoxynojirimycin, significantly increased the rate of basal ACE shedding and altered antibody-induced ACE shedding. A chemical cross-linking approach was used to show that ACE is present (at least in part) as noncovalently linked dimers on the surface of CHO-ACE cells. These results suggest a possible link between putative ACE dimerization on the cell surface and the proteolytic cleavage (shedding) of ACE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Deoxynojirimycin / analogs & derivatives
  • 1-Deoxynojirimycin / pharmacology
  • Animals
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / metabolism*
  • Antibody Specificity
  • CHO Cells
  • Carbohydrate Metabolism
  • Carbohydrates / pharmacology
  • Cattle
  • Cell Membrane / enzymology*
  • Cells, Cultured
  • Cricetinae
  • Cross-Linking Reagents / metabolism
  • Dimerization
  • Epitopes / metabolism*
  • Glucosidases / antagonists & inhibitors
  • Humans
  • Micelles
  • Peptidyl-Dipeptidase A / chemistry
  • Peptidyl-Dipeptidase A / immunology
  • Peptidyl-Dipeptidase A / metabolism*
  • Protein Structure, Tertiary
  • Water / chemistry

Substances

  • Antibodies, Monoclonal
  • Carbohydrates
  • Cross-Linking Reagents
  • Epitopes
  • Micelles
  • Water
  • 1-Deoxynojirimycin
  • miglustat
  • Glucosidases
  • Peptidyl-Dipeptidase A